Show Me the Data! Navigating FGFR, FGFR Resistance, Immunotherapy, and a World of Clinical Trials in Cholangiocarcinoma Treatment
Show Me the Data! Navigating FGFR, FGFR Resistance, Immunotherapy, and a World of Clinical Trials in Cholangiocarcinoma Treatment is organized by Physicians' Education Resource, LLC (PER).
Release Date: March 15, 2023
Expiration Date: March 15, 2024
Description:
This online, on-demand virtual symposium brings together renowned experts in the treatment of cholangiocarcinoma. In this educational program, these experts will provide an update on state-of-the-art treatment with immunotherapy and targeted therapeutic approaches in advanced cholangiocarcinoma, including recently released clinical trial results, best practices for adverse event management, and personalized treatment planning. This program will help clinicians who care for patients with cholangiocarcinoma gain additional knowledge and competence needed to provide optimal care plans.
This educational activity is an archive of the virtual symposium held on February 21, 2023.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Assess criteria and genomic information that allows for precision in the diagnosis of cholangiocarcinoma (CCA)
• Apply trial evidence that incorporated molecular marker information to guide therapeutic selection among patients with CCA
• Determine approaches to proactively identify and manage treatment-related toxicities in CCA care settings
• Describe recent findings from trials that evaluated emerging approaches to treat patients with CCA.
Additional details will be posted as soon as information is available.